Xenetic Biosciences Posts $0.72 GAAP Loss Per Share as Revenue Falls 29.4%

John Kim

1 min read

Add as a preferred source on Google

Xenetic Biosciences Posts $0.72 GAAP Loss Per Share as Revenue Falls 29.4%

Revenue totaled $0.7 million in the third quarter of 2026.

By John Kim

Published Nov 13, 2026, 11:48 AM EST

An earnings sheet folds downward beside a red glass weight / TokenPost.ai

Xenetic Biosciences, Inc. (XBIO) recorded a GAAP net loss per share of $0.72 for the third quarter of 2026 as revenue declined 29.4% year over year to $0.7 million.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.